Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Landstar System
LSTR
$6B
| – | – |
-8,133
| Closed | -$1.46M |
|
1827
Lyft
LYFT
$6.22B
| – | – |
-185,377
| Closed | -$1.72M |
|
1828
Masco
MAS
$14.7B
| – | – |
-9,907
| Closed | -$493K |
|
|
MASI
1829
DELISTED
Masimo
MASI
| – | – |
-4,345
| Closed | -$802K |
|
1830
Pediatrix Medical
MD
$2.16B
| – | – |
-44,163
| Closed | -$658K |
|
1831
Madrigal Pharmaceuticals
MDGL
$11.1B
| – | – |
-15,811
| Closed | -$3.83M |
|
1832
MGM Resorts International
MGM
$11.4B
| – | – |
-2,990,441
| Closed | -$133M |
|
1833
MGP Ingredients
MGPI
$370M
| – | – |
-3,433
| Closed | -$332K |
|
1834
Mirum Pharmaceuticals
MIRM
$6.38B
| – | – |
-154,750
| Closed | -$3.72M |
|
1835
Mesa Laboratories
MLAB
$584M
| – | – |
-2,435
| Closed | -$425K |
|
1836
Mueller Industries
MLI
$14.7B
| – | – |
-40,784
| Closed | -$749K |
|
1837
Mineralys Therapeutics
MLYS
$2.27B
| – | – |
-24,224
| Closed | -$379K |
|
|
MODV
1838
DELISTED
ModivCare
MODV
| – | – |
-2,416
| Closed | -$203K |
|
|
MPT
1839
Medical Properties Trust
MPT
$2.75B
| – | – |
-88,744
| Closed | -$729K |
|
1840
Marqeta
MQ
$1.88B
| – | – |
-227,096
| Closed | -$4.15M |
|
1841
nCino
NCNO
$2.1B
| – | – |
-1,715,503
| Closed | -$42.5M |
|
1842
New Fortress Energy
NFE
$95.9M
| – | – |
-8,651
| Closed | -$255K |
|
|
NIU
1843
Niu Technologies
NIU
$202M
| – | – |
-588,792
| Closed | -$2.44M |
|
1844
Nkarta
NKTX
$154M
| – | – |
-69,571
| Closed | -$247K |
|
1845
NOV
NOV
$6.94B
| – | – |
-473,610
| Closed | -$8.77M |
|
1846
NerdWallet
NRDS
$599M
| – | – |
-30,694
| Closed | -$497K |
|
1847
Nutanix
NTNX
$16.5B
| – | – |
-31,454
| Closed | -$817K |
|
1848
Novavax
NVAX
$1.22B
| – | – |
-17,585
| Closed | -$122K |
|
1849
Newell Brands
NWL
$2.7B
| – | – |
-12,762
| Closed | -$159K |
|
1850
NWPX Infrastructure Inc
NWPX
$1.23B
| – | – |
-82,468
| Closed | -$2.58M |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.